Another nail has been hammered into the coffin of the pharma model of providing lavish entertainment and other benefits to doctors to encourage prescribing of medicines.
Novartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused on activities in Greece and other countries, for $347 mi
With new phase 3 data in hand, Boehringer Ingelheim is preparing to file for approval of nerandolimast, a would-be successor to its blockbuster idiopathic pulmonary fibrosis (IPF) therapy O
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo